{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,11]],"date-time":"2026-09-11T05:07:50Z","timestamp":1789103270153,"version":"build-2803163510"},"reference-count":43,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2026,9,11]],"date-time":"2026-09-11T00:00:00Z","timestamp":1789084800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Endocrinol."],"abstract":"<jats:sec>\n                    <jats:title>Objective<\/jats:title>\n                    <jats:p>This systematic review and meta-analysis aimed to evaluate the effects of subclinical hypothyroidism (SCH) on serum levels of reproductive hormones, including follicle-stimulating hormone (FSH), luteinizing hormone (LH), estradiol, prolactin, and total testosterone, in women with polycystic ovary syndrome (PCOS) and to provide evidence for clinical practice.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>We searched PubMed, Web of Science, Embase, and Cochrane Library from inception to 25 April 2026 for relevant observational studies. Study quality was assessed using the Newcastle\u2013Ottawa Scale (NOS). Statistical analyses were performed using R software, with the standardized mean difference (SMD) and 95% confidence interval (CI) used as effect measures. Heterogeneity was evaluated using the I\u00b2 statistic, followed by subgroup analysis, sensitivity analysis, and publication bias tests.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      Thirteen studies involving 3,114 participants (579 PCOS patients with SCH and 2,535 euthyroid PCOS controls) were included. Pooled analyses showed no statistically significant differences in serum FSH, LH, estradiol, or total testosterone levels between groups. For prolactin, a significant elevation emerged after\n                      <jats:italic>post-hoc<\/jats:italic>\n                      exclusion of an outlying study contributing to extreme heterogeneity; this finding is exploratory. No significant publication bias was detected for FSH and LH; however, tests were underpowered for the other three outcomes, and Begg\u2019s test suggested potential small-study effects for prolactin. Certainty according to the Grading of Recommendations Assessment, Development and Evaluation (GRADE) framework was low for FSH and very low for LH, estradiol, prolactin, and total testosterone.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>Current evidence shows no significant differences in FSH, LH, estradiol, or total testosterone levels between SCH and euthyroid PCOS controls, while the evidence for prolactin remains uncertain. High heterogeneity and the observational study designs preclude definitive conclusions or causal inference.<\/jats:p>\n                    <jats:sec>\n                      <jats:title>Systematic Review Registration<\/jats:title>\n                      <jats:p>\n                        <jats:ext-link>https:\/\/www.crd.york.ac.uk\/PROSPERO\/view\/CRD420261382326<\/jats:ext-link>\n                        , identifier CRD420261382326.\n                      <\/jats:p>\n                    <\/jats:sec>\n                  <\/jats:sec>","DOI":"10.3389\/fendo.2026.1893428","type":"journal-article","created":{"date-parts":[[2026,9,11]],"date-time":"2026-09-11T04:33:25Z","timestamp":1789101205000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":0,"title":["The impact of subclinical hypothyroidism on core reproductive hormones and ovarian endocrine status in patients with polycystic ovary syndrome: a systematic review and meta-analysis"],"prefix":"10.3389","volume":"17","author":[{"given":"Yunhui","family":"Liu","sequence":"first","affiliation":[{"name":"Department of Endocrinology, Liuzhou Workers\u2019 Hospital, The Fourth Affiliated Hospital of Guangxi Medical University","place":["Guangxi, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tingting","family":"Deng","sequence":"additional","affiliation":[{"name":"Department of Endocrinology, Liuzhou Workers\u2019 Hospital, The Fourth Affiliated Hospital of Guangxi Medical University","place":["Guangxi, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ping","family":"Zhao","sequence":"additional","affiliation":[{"name":"Department of Endocrinology, Liuzhou Workers\u2019 Hospital, The Fourth Affiliated Hospital of Guangxi Medical University","place":["Guangxi, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2026,9,11]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.1016\/j.cmet.2025.08.002","article-title":"Polycystic ovary syndrome: a metabolic disorder with therapeutic opportunities","volume":"37","author":"Zhang","year":"2025","journal-title":"Cell Metab"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.1016\/j.fertnstert.2025.09.025","article-title":"Polycystic ovary syndrome in 2025-insights and innovations","volume":"124","author":"Dokras","year":"2025","journal-title":"Fertil Steril"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.86336","article-title":"Prevalence and risk factors of subclinical and overt hypothyroidism in Saudi Arabia: a systematic review","volume":"17","author":"Alhajri","year":"2025","journal-title":"Cureus"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.17722","article-title":"Frequency of subclinical hypothyroidism in women with polycystic ovary syndrome","volume":"13","author":"Raj","year":"2021","journal-title":"Cureus"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.31729\/jnma.8833","article-title":"Thyroid disorders in patients with polycystic ovarian syndrome in a tertiary care center: an observational study","volume":"62","author":"Sharma","year":"2024","journal-title":"JNMA"},{"key":"B6","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1186\/s12902-025-01896-2","article-title":"Prevalence of subclinical hypothyroidism in polycystic ovary syndrome and its impact on insulin resistance: a systematic review and meta-analysis","volume":"25","author":"Shekarian","year":"2025","journal-title":"BMC Endocr Disord"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.28468","article-title":"Influence of subclinical hypothyroidism on women with polycystic ovary syndrome: a literature review","volume":"14","author":"Peddemul","year":"2022","journal-title":"Cureus"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.1530\/eje-16-0611","article-title":"Management of endocrine disease: the impact of subclinical hypothyroidism on anthropometric characteristics, lipid, glucose and hormonal profile of PCOS patients: a systematic review and meta-analysis","volume":"176","author":"Pergialiotis","year":"2017","journal-title":"Eur J Endocrinol"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2018.00700","article-title":"Subclinical hypothyroidism in polycystic ovary syndrome: a systematic review and meta-analysis","volume":"9","author":"Ding","year":"2018","journal-title":"Front Endocrinol"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.1055\/a-1463-3198","article-title":"The impact of subclinical hypothyroidism on patients with polycystic ovary syndrome: a meta-analysis","volume":"53","author":"Xing","year":"2021","journal-title":"Horm Metab Res"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.3949\/ccjm.93a.25090","article-title":"Polycystic ovary syndrome: an update on diagnosis and management","volume":"9","author":"Sung","year":"2026","journal-title":"Cleveland Clin J Med"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2023.1251866","article-title":"Polycystic ovary syndrome and thyroid disorder: a comprehensive narrative review of the literature","volume":"14","author":"Palomba","year":"2023","journal-title":"Front Endocrinol"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.n71","article-title":"The PRISMA 2020 statement: an updated guideline for reporting systematic reviews","volume":"372","author":"Page","year":"2021","journal-title":"BMJ"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.1177\/0962280216669183","article-title":"Optimally estimating the sample mean from the sample size, median, mid-range, and\/or mid-quartile range","volume":"27","author":"Luo","year":"2018","journal-title":"Stat Methods Med Res"},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2288-14-135","article-title":"Estimating the sample mean and standard deviation from the sample size, median, range and\/or interquartile range","volume":"14","author":"Wan","year":"2014","journal-title":"BMC Med Res Methodol"},{"key":"B16","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1111\/jebm.12141","article-title":"The methodological quality assessment tools for preclinical and clinical studies, systematic review and meta-analysis, and clinical practice guideline: a systematic review","volume":"8","author":"Zeng","year":"2015","journal-title":"J Evidence-Based Med"},{"key":"B17","first-page":"1","article-title":"The Newcastle-Ottawa scale (NOS) for assessing the quality of nonrandomised studies in meta-analyses","author":"Peterson","year":"2011"},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.1177\/11795514251343678","article-title":"Subclinical hypothyroidism in polycystic ovary syndrome: prevalence and impact on metabolic and cardiovascular risk","volume":"18","author":"Ach","year":"2025","journal-title":"Clin Med Insights Endocrinol Diabetes"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.8142","article-title":"Correlation of subclinical hypothyroidism with polycystic ovary syndrome (PCOS)","volume":"12","author":"Fatima","year":"2020","journal-title":"Cureus J Med Sci"},{"key":"B20","doi-asserted-by":"publisher","first-page":"20160058","DOI":"10.1515\/hmbci-2016-0058","article-title":"Subclinical hypothyroidism does not inflluence the metabolic and hormonal profile of women with PCOS","volume":"31","author":"Trakakis","year":"2017","journal-title":"Hormone Mol Biol Clin Invest"},{"key":"B21","doi-asserted-by":"publisher","first-page":"725","DOI":"10.1186\/s40001-025-02910-y","article-title":"Impact of subclinical hypothyroidism on endocrine features in patients with polycystic ovary syndrome","volume":"30","author":"Hua","year":"2025","journal-title":"Eur J Med Res"},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.2147\/IJWH.S517997","article-title":"The influence of subclinical hypothyroidism on endocrine and metabolic characteristics in patients with polycystic ovary syndrome","volume":"17","author":"Dai","year":"2025","journal-title":"Int J Women's Health"},{"key":"B23","doi-asserted-by":"publisher","DOI":"10.7417\/ct.2026.1983","article-title":"Metabolic and hormonal impact of subclinical hypothyroidism in women with polycystic ovary syndrome: a cross-sectional study from South India","volume":"177","author":"Acharya","year":"2026","journal-title":"La Clin Terapeutica"},{"key":"B24","doi-asserted-by":"publisher","DOI":"10.17925\/ee.2020.16.2.156","article-title":"Impact of subclinical hypothyroidism on reproductive and metabolic parameters in polycystic ovary syndrome - a cross-sectional study from Bangladesh","volume":"16","author":"Kamrul-Hasan","year":"2020","journal-title":"Eur Endocrinol"},{"key":"B25","doi-asserted-by":"publisher","DOI":"10.1080\/09513590.2024.2358219","article-title":"The effect of subclinical hypothyroidism on hormonal and metabolic profiles and ovarian morphology in patients with polycystic ovary syndrome: a cross-sectional study","volume":"40","author":"Shi","year":"2024","journal-title":"Gynecol Endocrinol"},{"key":"B26","doi-asserted-by":"publisher","DOI":"10.4081\/jbr.2025.13712","article-title":"Impact of subclinical hypothyroidism on clinical, hormonal, and metabolic parameters in women with polycystic ovary syndrome: the role of levothyroxine therapy","volume":"98","author":"Qasim","year":"2025","journal-title":"J Biol Res"},{"key":"B27","doi-asserted-by":"publisher","DOI":"10.3390\/jcm11061547","article-title":"Association of subclinical hypothyroidism with present and absent anti-thyroid antibodies with PCOS phenotypes and metabolic profile","volume":"11","author":"Gawron","year":"2022","journal-title":"J Clin Med"},{"key":"B28","article-title":"Should subclinical hypothyroidism be an exclusion criterion for the diagnosis of polycystic ovary syndrome","volume":"18","author":"Freitas De-Medeiros","year":"2017","journal-title":"J Reprod Infertil"},{"key":"B29","doi-asserted-by":"publisher","DOI":"10.1080\/09513590.2016.1183193","article-title":"Subclinical hypothyroidism is associated with metabolic syndrome and clomiphene citrate resistance in women with polycystic ovary syndrome","volume":"32","author":"Lu","year":"2016","journal-title":"Gynecological Endocrinol"},{"key":"B30","doi-asserted-by":"publisher","DOI":"10.1155\/2016\/2067087","article-title":"Subclinical hypothyroidism in PCOS: impact on presentation, insulin resistance, and cardiovascular risk","volume":"2016","author":"Yu","year":"2016","journal-title":"BioMed Res Int"},{"key":"B31","doi-asserted-by":"publisher","DOI":"10.2174\/1573399818666220426090324","article-title":"Is there a relation between hypothyroidism and polycystic ovary syndrome and its metabolic components","volume":"19","author":"Bonakdaran","year":"2023","journal-title":"Curr Diabetes Rev"},{"key":"B32","doi-asserted-by":"publisher","DOI":"10.1089\/jwh.2017.6584","article-title":"Clinical, hormonal, and metabolic parameters in women with subclinical hypothyroidism and polycystic ovary syndrome: a cross-sectional study","volume":"27","author":"Bedaiwy","year":"2018","journal-title":"J Women's Health"},{"key":"B33","doi-asserted-by":"publisher","DOI":"10.1210\/endocr\/bqad155","article-title":"Sustained pituitary T3 production explains the T4-mediated TSH feedback mechanism","volume":"164","author":"Batistuzzo","year":"2023","journal-title":"Endocrinology"},{"key":"B34","doi-asserted-by":"publisher","DOI":"10.1002\/rmb2.12487","article-title":"Pathophysiology of polycystic ovary syndrome revisited: current understanding and perspectives regarding future research","volume":"21","author":"Harada","year":"2022","journal-title":"Reprod Med Biol"},{"key":"B35","doi-asserted-by":"publisher","DOI":"10.53730\/IJHS.V6NS5.10565","article-title":"A study regarding the interrelation between subclinical hypothyroidism & insulin resistance among PCOS women","volume":"6","author":"Rosivari","year":"2022","journal-title":"Int J Health Sci"},{"key":"B36","doi-asserted-by":"publisher","DOI":"10.69605\/ijlbpr_13.8.2024.59","article-title":"Current insights into the diagnosis and management of subclinical hypothyroidism: a systematic review","volume":"13","author":"Hamid","year":"2024","journal-title":"Int J Life Sci Bio\/Technol Pharm Res"},{"key":"B37","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2023.1242050","article-title":"The role of the thyroid in polycystic ovary syndrome","volume":"14","author":"Fan","year":"2023","journal-title":"Front Endocrinol"},{"key":"B38","doi-asserted-by":"publisher","DOI":"10.4239\/WJD.V12.i5.616","article-title":"Role of insulin and insulin resistance in androgen excess disorders","volume":"12","author":"Unluhizarci","year":"2021","journal-title":"World J Diabetes"},{"key":"B39","doi-asserted-by":"publisher","DOI":"10.4183\/aeb.2016.431","article-title":"Is subclinical hypothyroidism in patients with polycystic ovary syndrome associated with BMI","volume":"12","author":"Yasar","year":"2016","journal-title":"Acta Endocrinol (Bucharest)"},{"key":"B40","doi-asserted-by":"publisher","DOI":"10.1002\/dmrr.3836","article-title":"A century of prolactin: emerging perspectives as a metabolic regulator","volume":"40","author":"Wu","year":"2024","journal-title":"Diabetes\/Metabol Res Rev"},{"key":"B41","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1016\/j.bioana.2025.06.002","article-title":"Multi-omics analysis reveals synergistic interplay of metabolic dysregulation, oxidative stress, and inflammation in polycystic ovary syndrome","volume":"2","author":"Chen","year":"2025","journal-title":"Biomed Anal"},{"key":"B42","doi-asserted-by":"publisher","DOI":"10.1093\/ejendo\/lvad096","article-title":"Recommendations from the 2023 international evidence-based guideline for the assessment and management of polycystic ovary syndrome","volume":"189","author":"Teede","year":"2023","journal-title":"Eur J Endocrinol"},{"key":"B43","doi-asserted-by":"publisher","DOI":"10.1089\/thy.2016.0457","article-title":"2017 guidelines of the American Thyroid Association for the diagnosis and management of thyroid disease during pregnancy and the postpartum","volume":"27","author":"Alexander","year":"2017","journal-title":"Thyroid"}],"container-title":["Frontiers in Endocrinology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fendo.2026.1893428\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,11]],"date-time":"2026-09-11T04:33:34Z","timestamp":1789101214000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fendo.2026.1893428\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9,11]]},"references-count":43,"alternative-id":["10.3389\/fendo.2026.1893428"],"URL":"https:\/\/doi.org\/10.3389\/fendo.2026.1893428","relation":{},"ISSN":["1664-2392"],"issn-type":[{"value":"1664-2392","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,9,11]]},"article-number":"1893428"}}